FDA Approved: ZEMDRI (PLAZOMICIN) — Supplemental Application (Cipla Therapeutics Inc.)

View source ↗

Summary

FDA approved a supplemental application for ZemdrI (plazomicin) submitted by Cipla Therapeutics Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• ZEMDRI (plazomicin)

Snippet

SUPPL AP for ZEMDRI (PLAZOMICIN) (PLAZOMICIN)